These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29958681)

  • 61. Rapid structure elucidation of drug degradation products using mechanism-based stress studies in conjunction with LC-MS(n) and NMR spectroscopy: identification of a photodegradation product of betamethasone dipropionate.
    Lin M; Li M; Buevich AV; Osterman R; Rustum AM
    J Pharm Biomed Anal; 2009 Oct; 50(3):275-80. PubMed ID: 19525081
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stability-Indicating Related Substances HPLC Method for Droxidopa and Characterization of Related Substances Using LC-MS and NMR.
    Kumar T; Ramya M; Arockiasamy Xavier SJ
    J Chromatogr Sci; 2016 Nov; 54(10):1761-1770. PubMed ID: 27601041
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hyphenated liquid chromatography - diode array detection - charged aerosol detection - high resolution - multistage mass spectrometry with online hydrogen/deuterium exchange: One stop solution for pharmaceutical impurity profiling.
    Thakkar H; Jain S; Kumar S; Bhalekar VS; Gangakhedkar S; Shah RP
    J Chromatogr A; 2023 Jan; 1689():463725. PubMed ID: 36586282
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of an unknown impurity in doxofylline using LC-MS and NMR.
    Zhu P; Lu J; Hong L; Su W; Van Schepdael A; Adams E
    J Pharm Biomed Anal; 2017 Jun; 140():31-37. PubMed ID: 28340472
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Supercritical fluid chromatography-photodiode array detection-electrospray ionization mass spectrometry as a framework for impurity fate mapping in the development and manufacture of drug substances.
    Pirrone GF; Mathew RM; Makarov AA; Bernardoni F; Klapars A; Hartman R; Limanto J; Regalado EL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1080():42-49. PubMed ID: 29477066
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification and characterization of new impurity in didanosine.
    Srinivasa Rao DV; Srinivas N; Bharathi Ch; Prasad ChS; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Nov; 45(3):516-20. PubMed ID: 17624711
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Synthesis, isolation, identification and characterization of new process-related impurity in isoproterenol hydrochloride by HPLC, LC/ESI-MS and NMR.
    Kumar N; Devineni SR; Gajjala PR; Dubey SK; Kumar P
    J Pharm Anal; 2017 Dec; 7(6):394-400. PubMed ID: 29404065
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Optimization of a two-dimensional liquid chromatography-supercritical fluid chromatography-mass spectrometry (2D-LC-SFS-MS) system to assess "in-vivo" inter-conversion of chiral drug molecules.
    Goel M; Larson E; Venkatramani CJ; Al-Sayah MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():89-95. PubMed ID: 29579733
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmaceutical impurity identification: a case study using a multidisciplinary approach.
    Alsante KM; Boutros P; Couturier MA; Friedmann RC; Harwood JW; Horan GJ; Jensen AJ; Liu Q; Lohr LL; Morris R; Raggon JW; Reid GL; Santafianos DP; Sharp TR; Tucker JL; Wilcox GE
    J Pharm Sci; 2004 Sep; 93(9):2296-309. PubMed ID: 15295790
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification and quantification of five impurities in cloperastine hydrochloride.
    Liu HY; Cheng QZ; Fu HZ; Zhong ZH; Xia HY; Guo YF; Zheng SS; Yu SS
    J Pharm Biomed Anal; 2021 Jan; 193():113731. PubMed ID: 33197833
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of a trace colored impurity in drug substance by preparative liquid chromatography and mass spectrometry.
    Wang P; Shi YJ; Helmy R; Reamer R; Vailaya A
    Rapid Commun Mass Spectrom; 2005; 19(24):3749-54. PubMed ID: 16308847
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Practical comparison of 2.7 microm fused-core silica particles and porous sub-2 microm particles for fast separations in pharmaceutical process development.
    Abrahim A; Al-Sayah M; Skrdla P; Bereznitski Y; Chen Y; Wu N
    J Pharm Biomed Anal; 2010 Jan; 51(1):131-7. PubMed ID: 19758782
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Simultaneous relative UV response determination of known liquid drug product degradants by NMR spectroscopy.
    Samuels ER; Wang T
    J Pharm Biomed Anal; 2022 May; 213():114665. PubMed ID: 35217258
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assay at low ppm level of dimethyl sulfate in starting materials for API synthesis using derivatization in ionic liquid media and LC-MS.
    Grinberg N; Albu F; Fandrick K; Iorgulescu E; Medvedovici A
    J Pharm Biomed Anal; 2013 Mar; 75():1-6. PubMed ID: 23312378
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mismatch between sample diluent and eluent: Maintaining integrity of gradient peaks using in silico approaches.
    Gritti F; Gilar M; Hill J
    J Chromatogr A; 2019 Dec; 1608():460414. PubMed ID: 31416623
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development and validation of a sensitive GC-MS method for the determination of trace levels of an alkylating reagent in a beta-lactam active pharmaceutical ingredient.
    Li H; Sluggett GW
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):486-94. PubMed ID: 15951149
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Separation and purification of iopamidol using preparative high-performance liquid chromatography].
    Li H; Chen Q
    Se Pu; 2018 Oct; 36(10):1061-1066. PubMed ID: 30378367
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Detection, identification and quantification of a new de-fluorinated impurity in casopitant mesylate drug substance during late phase development: an analytical challenge involving a multidisciplinary approach.
    Turco L; Provera S; Curcuruto O; Bernabè E; Nicoletti A; Martini L; Castoldi D; Cimarosti Z; Papini D; Marchioro C; Dams R
    J Pharm Biomed Anal; 2011 Jan; 54(1):67-73. PubMed ID: 20813481
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Isolation and identification of four major impurities in capreomycin sulfate.
    Liu G; Luan B; Liang G; Xing L; Huang L; Wang C; Xu Y
    J Chromatogr A; 2018 Oct; 1571():155-164. PubMed ID: 30115387
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of two modified quick, easy, cheap, effective, rugged and safe (QuEChERS) sample preparation methods for the analysis of baclofen and gabapentin in feeds by liquid chromatography tandem mass spectrometry.
    Hou XL; Wu YL; Chen RX; Zhu Y; Lv Y; Xu XQ
    J Pharm Biomed Anal; 2014 Jan; 88():53-9. PubMed ID: 24036362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.